Eucrates Biomedical Acquisition - Warrants (23/10/2027) Total Liabilities

As of the most recent data (December 2022), EUCRW shows a total liabilities of $3.9M. That compares with $5.8M in the prior-year period — down 31.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, EUCRW's total liabilities is now $3.9M (was $5.8M) — a 31.9% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Eucrates Biomedical Acquisition - Warrants (23/10/2027) is outperforming or lagging.

Tracking EUCRW's total liabilities over time shows whether Eucrates Biomedical Acquisition - Warrants (23/10/2027) is scaling, shrinking, or reshaping that part of the business. The current reading is $3.9M That compares with $5.8M in the prior-year period — down 31.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has Eucrates Biomedical Acquisition - Warrants (23/10/2027)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $3.9M) with ownership activity and broader fundamentals.